• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国带状疱疹流行病学的基于人群的研究。

Population-based study of the epidemiology of herpes zoster in Korea.

作者信息

Kim You Jeong, Lee Chang Nam, Lim Chi-Yeon, Jeon Woo Seok, Park Young Min

机构信息

SaeHaYan Dermatology Clinic, Gwangmyeong, Korea.

DM/STATISTICS Institute, School of Medicine, Dongguk University, Goyang, Korea.

出版信息

J Korean Med Sci. 2014 Dec;29(12):1706-10. doi: 10.3346/jkms.2014.29.12.1706. Epub 2014 Nov 21.

DOI:10.3346/jkms.2014.29.12.1706
PMID:25469074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4248595/
Abstract

General epidemiological data regarding herpes zoster (HZ) are necessary for treatment and prevention of this disease. In addition, epidemiological data can play an important role in evaluating the efficacy and impact of vaccination. Though several epidemiological studies of HZ in Korea have been conducted, they usually depend on hospital-based data and may not be representative of HZ characteristics all over Korea. The purpose of this study was to evaluate the incidence and other epidemiological features of HZ in the general Korean population. We used population-based medical records from the Health Insurance Review & Assessment Service, which includes 50,908,646 medical insurance subscribers, to calculate the incidence of HZ. Also, we analyzed an age-stratified random sample of 1,375,842 individuals to study descriptive epidemiologic characteristics of HZ in Korea in 2011. We observed that the incidence of HZ was 10.4 per 1,000 person-years and was strongly correlated with age. Sex had a major influence on HZ incidence; overall, there were 12.6 cases per 1,000 person years in women and 8.3 cases per 1,000 person years in men. There was no difference in incidence according to the locality and season.

摘要

有关带状疱疹(HZ)的一般流行病学数据对于该疾病的治疗和预防至关重要。此外,流行病学数据在评估疫苗接种的效果和影响方面可发挥重要作用。尽管韩国已经开展了多项关于HZ的流行病学研究,但这些研究通常依赖于基于医院的数据,可能无法代表全韩国HZ的特征。本研究的目的是评估韩国普通人群中HZ的发病率及其他流行病学特征。我们使用了健康保险审查与评估服务机构基于人群的医疗记录(其中包括50,908,646名医疗保险参保人)来计算HZ的发病率。此外,我们分析了1,375,842人的年龄分层随机样本,以研究2011年韩国HZ的描述性流行病学特征。我们观察到,HZ的发病率为每1000人年10.4例,且与年龄密切相关。性别对HZ发病率有重大影响;总体而言,女性每1000人年有12.6例,男性每1000人年有8.3例。发病率在地区和季节方面没有差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/63c655c1357d/jkms-29-1706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/809beaa4b328/jkms-29-1706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/0c22f41734e1/jkms-29-1706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/2feb863ec69c/jkms-29-1706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/63c655c1357d/jkms-29-1706-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/809beaa4b328/jkms-29-1706-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/0c22f41734e1/jkms-29-1706-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/2feb863ec69c/jkms-29-1706-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59a4/4248595/63c655c1357d/jkms-29-1706-g004.jpg

相似文献

1
Population-based study of the epidemiology of herpes zoster in Korea.韩国带状疱疹流行病学的基于人群的研究。
J Korean Med Sci. 2014 Dec;29(12):1706-10. doi: 10.3346/jkms.2014.29.12.1706. Epub 2014 Nov 21.
2
Disease burden of herpes zoster in Korea.韩国带状疱疹的疾病负担。
J Clin Virol. 2010 Apr;47(4):325-9. doi: 10.1016/j.jcv.2010.01.003. Epub 2010 Feb 24.
3
Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003-2013.2003-2013 年马德里(西班牙)带状疱疹相关住院治疗的时间趋势。
J Infect. 2015 Jul;71(1):85-92. doi: 10.1016/j.jinf.2015.01.015. Epub 2015 Mar 3.
4
Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability.带状疱疹相关住院病例的特征马德里(西班牙)在疫苗可获得性之前。
J Infect. 2016 Jan;72(1):70-9. doi: 10.1016/j.jinf.2015.10.003. Epub 2015 Oct 20.
5
The changing epidemiology of herpes zoster over a decade in South Korea, 2006-2015.韩国十余年来带状疱疹的流行情况变化:2006-2015 年。
Vaccine. 2019 Aug 23;37(36):5153-5160. doi: 10.1016/j.vaccine.2019.07.086. Epub 2019 Jul 31.
6
A population based study of the epidemiology of Herpes Zoster and its complications.基于人群的带状疱疹及其并发症的流行病学研究。
J Infect. 2013 Nov;67(5):463-9. doi: 10.1016/j.jinf.2013.06.016. Epub 2013 Jul 16.
7
Incidence of herpes zoster and its complications in Germany, 2005-2009.2005-2009 年德国带状疱疹及其并发症的发病情况。
J Infect. 2015 Feb;70(2):178-86. doi: 10.1016/j.jinf.2014.08.018. Epub 2014 Sep 16.
8
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan.台湾地区疫苗接种前带状疱疹的疾病负担和流行病学。
Vaccine. 2010 Feb 3;28(5):1217-20. doi: 10.1016/j.vaccine.2009.11.029. Epub 2009 Nov 26.
9
Epidemiology of herpes zoster and its relationship to varicella in Japan: A 10-year survey of 48,388 herpes zoster cases in Miyazaki prefecture.日本带状疱疹的流行病学及其与水痘的关系:10 年对宫崎县 48388 例带状疱疹病例的调查。
J Med Virol. 2009 Dec;81(12):2053-8. doi: 10.1002/jmv.21599.
10
The epidemiology of herpes zoster in patients with newly diagnosed cancer.新发癌症患者中带状疱疹的流行病学。
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. doi: 10.1158/1055-9965.EPI-12-0815. Epub 2012 Nov 1.

引用本文的文献

1
Incidence and clinical profile of herpes zoster in primary care in Bahrain - A cross-sectional study.巴林初级保健中带状疱疹的发病率及临床特征——一项横断面研究
Qatar Med J. 2025 Aug 22;2025(3):72. doi: 10.5339/qmj.2025.72. eCollection 2025.
2
Herpes zoster infection in patients with inflammatory bowel disease.炎症性肠病患者的带状疱疹感染
Korean J Intern Med. 2025 May;40(3):347-356. doi: 10.3904/kjim.2024.342. Epub 2025 Apr 30.
3
A systematic review and meta-analysis of herpes zoster risk in adults with immunocompromised conditions and autoimmune diseases in Asia-Pacific.

本文引用的文献

1
The global epidemiology of herpes zoster.带状疱疹的全球流行病学。
Neurology. 2013 Sep 3;81(10):928-30. doi: 10.1212/WNL.0b013e3182a3516e.
2
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.带状疱疹疫苗在 50-59 岁人群中的疗效、安全性和耐受性。
Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.
3
The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008.2000-2008 年台湾地区水痘疫苗覆盖率增加期间水痘和带状疱疹发病率。
亚太地区免疫功能低下和自身免疫性疾病成人带状疱疹风险的系统评价与荟萃分析
Hum Vaccin Immunother. 2025 Dec;21(1):2496048. doi: 10.1080/21645515.2025.2496048. Epub 2025 Apr 29.
4
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment.韩国50岁及以上人群对带状疱疹疫苗的偏好:离散选择实验的结果
Hum Vaccin Immunother. 2025 Dec;21(1):2469419. doi: 10.1080/21645515.2025.2469419. Epub 2025 Mar 10.
5
Burden of Herpes Zoster in Individuals With Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study.韩国慢性病患者的带状疱疹负担:一项基于全国人口数据库的研究。
Open Forum Infect Dis. 2024 Sep 18;11(10):ofae535. doi: 10.1093/ofid/ofae535. eCollection 2024 Oct.
6
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.亚太地区部分地区带状疱疹的流行病学和疾病负担的系统文献回顾。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20.
7
Knowledge, attitude, and practice toward herpes zoster (HZ) and HZ vaccination: Concept elicitation findings from a multi-country study in the Asia Pacific.对带状疱疹(HZ)及HZ疫苗的知识、态度和实践:亚太地区一项多国研究的概念激发性研究结果
Hum Vaccin Immunother. 2024 Dec 31;20(1):2317446. doi: 10.1080/21645515.2024.2317446. Epub 2024 Mar 4.
8
Genetic polymorphisms of and postherpetic pain susceptibility: Multicenter, randomized control, and haplotype analysis study.[具体基因名称]的基因多态性与带状疱疹后神经痛易感性:多中心、随机对照及单倍型分析研究
Front Mol Neurosci. 2023 Feb 1;16:1128429. doi: 10.3389/fnmol.2023.1128429. eCollection 2023.
9
Safety and efficacy of long-term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open.OCTAVE Open 中,托法替布治疗东亚溃疡性结肠炎患者的长期安全性和疗效。
J Gastroenterol Hepatol. 2022 Oct;37(10):1884-1892. doi: 10.1111/jgh.15923. Epub 2022 Jul 21.
10
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.全球带状疱疹发病率、疾病负担及疫苗可及性:一项叙述性综述
Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022.
Epidemiol Infect. 2012 Jun;140(6):1131-40. doi: 10.1017/S0950268811001786. Epub 2011 Sep 12.
4
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.意大利带状疱疹及带状疱疹后神经痛的流行病学和经济负担:一项回顾性、基于人群的研究。
BMC Infect Dis. 2010 Aug 3;10:230. doi: 10.1186/1471-2334-10-230.
5
Herpes zoster: a common disease that can have a devastating impact on patients' quality of life.带状疱疹:一种常见的疾病,会对患者的生活质量造成严重影响。
Expert Rev Vaccines. 2010 Mar;9(3 Suppl):27-30. doi: 10.1586/erv.10.31.
6
Herpes zoster and postherpetic neuralgia.带状疱疹和带状疱疹后神经痛。
Expert Rev Vaccines. 2010 Mar;9(3 Suppl):21-6. doi: 10.1586/erv.10.30.
7
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.英国带状疱疹及带状疱疹后神经痛的流行病学与成本
Epidemiol Infect. 2009 Jan;137(1):38-47. doi: 10.1017/S0950268808000678. Epub 2008 May 9.
8
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.一项在引入带状疱疹疫苗之前基于人群的带状疱疹发病率和并发症发生率研究。
Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341.
9
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.一种预防老年人带状疱疹及带状疱疹后神经痛的疫苗。
N Engl J Med. 2005 Jun 2;352(22):2271-84. doi: 10.1056/NEJMoa051016.
10
What does epidemiology tell us about risk factors for herpes zoster?流行病学能告诉我们关于带状疱疹的危险因素有哪些?
Lancet Infect Dis. 2004 Jan;4(1):26-33. doi: 10.1016/s1473-3099(03)00857-0.